Key Activities and Accomplishments
• Demonstrated a model that is increasing antiretroviral therapy (ART) coverage and viral load suppression in Yunnan, the province in China with the highest burden of HIV, while strengthening the capacity of AIDS Care China, which is one of China’s most important civil society organizations.
• Helped launch first publicly-supported HIV pre-exposure prophylaxis program in China in Tianjin
• Partnered with China CDC, Yunnan CDC, Kunming CDC, BlueD, and community groups to carry out 3-source capture-recapture-based Men who have Sex with Men (MSM) population size estimation study in Kunming.
• Coauthored several scientific publications describing joint projects carried out in recent years, including an analysis of Chinese national HIV treatment program and surveillance data to compare outcomes of HIV-Infected Chinese adults on antiretroviral therapy by CD4 count at treatment initiation.
• Collaborated to develop protocol for a study of HIV incidence among MSM in two large Chinese provincial capital cities with respondent driven sampling used for recruitment; study launch anticipated in summer, 2018
Tuberculosis (PEPFAR and Non-PEPFAR)
• Surveillance: To help reduce the number of TB cases “missed” by the surveillance network (unreported), build a platform to routinely identify and report on diagnosed cases that are not reported in surveillance systems in six counties throughout China using a standardized tool-kit (pilot inventory study).
• Infection Control: Improve TB infection control training and implementation using CDC’s TB BASICS model to prevent transmission of TB and MDR TB in health care facilities.
• Laboratory: Strengthen laboratory management practices and the use of quality diagnostics to improve TB and MDR TB case finding through the development and implementation of a national laboratory strategic plan, and through demonstration and evaluation of effective algorithms using new TB diagnostics such as GeneXpert MTB/RIF®.
• TB/HIV: Implement the demonstration project of the “Three I’s” strategies among people living with HIV in two provinces in China: (1) improve infection control practices; (2) intensified TB case finding using GeneXpert MTB/RIF®; and (3) the provision of isoniazid preventative therapy.